CN107510044A - 一种肝病临床营养配方及其制备方法 - Google Patents
一种肝病临床营养配方及其制备方法 Download PDFInfo
- Publication number
- CN107510044A CN107510044A CN201710808664.4A CN201710808664A CN107510044A CN 107510044 A CN107510044 A CN 107510044A CN 201710808664 A CN201710808664 A CN 201710808664A CN 107510044 A CN107510044 A CN 107510044A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- liver disease
- nutrient formulation
- clinical liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000019423 liver disease Diseases 0.000 title claims abstract description 38
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 28
- 238000009472 formulation Methods 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 36
- 229940088594 vitamin Drugs 0.000 claims abstract description 14
- 229930003231 vitamin Natural products 0.000 claims abstract description 14
- 235000013343 vitamin Nutrition 0.000 claims abstract description 14
- 239000011782 vitamin Substances 0.000 claims abstract description 14
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 14
- 229920002472 Starch Polymers 0.000 claims abstract description 12
- 235000019698 starch Nutrition 0.000 claims abstract description 12
- 239000008107 starch Substances 0.000 claims abstract description 12
- 235000018102 proteins Nutrition 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 8
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 8
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 7
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 7
- 239000011707 mineral Substances 0.000 claims abstract description 7
- 235000010755 mineral Nutrition 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 10
- 229930003268 Vitamin C Natural products 0.000 claims description 10
- 235000019154 vitamin C Nutrition 0.000 claims description 10
- 239000011718 vitamin C Substances 0.000 claims description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 9
- 235000019155 vitamin A Nutrition 0.000 claims description 9
- 239000011719 vitamin A Substances 0.000 claims description 9
- 229940045997 vitamin a Drugs 0.000 claims description 9
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- 241000245613 Hypnum Species 0.000 claims description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 8
- 229930003316 Vitamin D Natural products 0.000 claims description 8
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 8
- 235000019166 vitamin D Nutrition 0.000 claims description 8
- 239000011710 vitamin D Substances 0.000 claims description 8
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 229940046008 vitamin d Drugs 0.000 claims description 8
- 235000019733 Fish meal Nutrition 0.000 claims description 7
- 239000004467 fishmeal Substances 0.000 claims description 7
- 239000004575 stone Substances 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- 108010024636 Glutathione Proteins 0.000 claims description 4
- 241000238631 Hexapoda Species 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 4
- -1 digested tankage Substances 0.000 claims description 4
- 235000019197 fats Nutrition 0.000 claims description 4
- 229960003180 glutathione Drugs 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 235000019198 oils Nutrition 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 4
- 229960001763 zinc sulfate Drugs 0.000 claims description 4
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- 229930003448 Vitamin K Natural products 0.000 claims description 3
- 235000013793 astaxanthin Nutrition 0.000 claims description 3
- 239000001168 astaxanthin Substances 0.000 claims description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 3
- 229940022405 astaxanthin Drugs 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 235000019158 vitamin B6 Nutrition 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000019168 vitamin K Nutrition 0.000 claims description 3
- 239000011712 vitamin K Substances 0.000 claims description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- 229940046010 vitamin k Drugs 0.000 claims description 3
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 241000206575 Chondrus crispus Species 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229940041514 candida albicans extract Drugs 0.000 claims description 2
- 235000012682 canthaxanthin Nutrition 0.000 claims description 2
- 239000001659 canthaxanthin Substances 0.000 claims description 2
- 229940008033 canthaxanthin Drugs 0.000 claims description 2
- 239000002385 cottonseed oil Substances 0.000 claims description 2
- 235000012343 cottonseed oil Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- YPJCVYYCWSFGRM-UHFFFAOYSA-H iron(3+);tricarbonate Chemical compound [Fe+3].[Fe+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O YPJCVYYCWSFGRM-UHFFFAOYSA-H 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000009973 maize Nutrition 0.000 claims description 2
- 125000003071 maltose group Chemical group 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 239000008159 sesame oil Substances 0.000 claims description 2
- 235000011803 sesame oil Nutrition 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 1
- 244000000626 Daucus carota Species 0.000 claims 1
- 235000002767 Daucus carota Nutrition 0.000 claims 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 13
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 239000002417 nutraceutical Substances 0.000 abstract description 3
- 235000021436 nutraceutical agent Nutrition 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 230000003908 liver function Effects 0.000 abstract description 2
- 231100000753 hepatic injury Toxicity 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- 206010067125 Liver injury Diseases 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 2
- 206010019842 Hepatomegaly Diseases 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010041519 Spider naevus Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000037902 enteropathy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000007232 portal hypertension Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了属于肝病营养品技术领域的一种肝病临床营养配方及其制备方法。由如下重量份数的组分组成：蛋白质300‑500份，脂肪100‑200份，糖类120‑230份，淀粉300‑600份，维生素0.05‑1份，矿物质3‑8份，天然植物干粉末10‑30份，增稠剂15‑80份，抗氧化剂0.1‑2份。本发明制备的肝病临床营养食品，具有护肝养肝的功效，选取天然植物干粉末作为护肝养肝的活性组分，配合蛋白质，脂肪，糖类，淀粉等营养物质，以及维生素，矿物质，抗氧化剂等有益因子，最大化恢复肝病病人的肝脏功能。
Description
技术领域
本发明属于肝病营养品技术领域，具体涉及一种肝病临床营养配方及其制备方法。
背景技术
肝病是指发生在肝脏的病变，包括乙肝、甲肝、丙肝、肝硬化、脂肪化、肝癌、酒精肝等等多种肝病。肝病的主要表现有：恶心、厌油腻、食欲差等，可出现呕吐，腹泻，脾肿大等症状，此类症状也可能与慢性肝病引起的肝原性溃疡病，门静脉高压性肠病等有关；肝区不适和肝区疼痛较具有特异性，往往与肝肿大压迫肝包膜有关，随着病情的转归，肝肿大的加重或减轻，肝区疼痛的性质和程度也不相同；身体乏力、容易疲劳是最常见的全身表现，部分肝病患者可伴有不同程度黄疸，表现为尿黄、眼睛黄和皮肤黄，是最具有特异性的肝病症状；很多慢性肝病会出现肝掌、蜘蛛痣、肝病面容，尤其肝硬化病人比较多见，肝病出血现象体现在肝功能减退，使凝血因子合成减少所致，容易引起肝病患者牙龈出血、痔疮出血、胃肠道出血等，且出血时难以止住。
肝脏对于糖类，脂类，蛋白质的代谢起着关键的作用，对于肝病患者，合理的膳食和营养对于肝病的治疗和肝脏的恢复起着重要的作用。专利201410260526.3公开了一种适合肝病病人的营养膳，由以下重量百分比原料组成：膨化粉10％～30％、麦芽糊精12％～32％、奶粉8％～25％、全脂大豆粉2％～10％、水解乳清蛋白2％～8％、乳清蛋白3％～10％、牛磺酸0.2％～0.8％、精氨酸0.3％～0.9％、谷胱甘肽0.1％～0.5％、粉末油脂2％～8％、粉末中链油2％～8％、菊粉2％～10％、白砂糖粉3％～9％、三聚磷酸钠0.2％～1％、氯化钾0.1％～0.8％、乳酸钙0.2％～0.8％、葡萄糖酸镁0.2％～0.8％、维生素A0.0001％～0.0003％、维生素B10.0001％～0.0003％、维生素B20.0001％～0.0003％、维生素B60.0001％～0.0003％、维生素C0.01％～0.03％、L-肉碱0.1％～0.3％、肌醇0.06％～0.15％。该膳食配方对于对 CCl4 亚急性肝损伤小鼠具有肝损伤保护作用，但是对于其他原因引起的肝脏损伤没有作用，专一性强，应用范围窄。
发明内容
本发明的目的在于提供一种肝病临床营养食品及其制备方法。
一种肝病临床营养配方，由如下重量份数的组分组成：蛋白质300-500份，脂肪100-200份，糖类120-230份，淀粉300-600份，维生素0.05-1份，矿物质3-8份，天然植物干粉末10-30份，增稠剂15-80份，抗氧化剂0.1-2份。
所述蛋白质为鱼粉，肉粉，蛋白胨，酵母提取物中的一种或一种以上。
所述蛋白质为三虫粉。
所述脂肪为猪油，花生油，大豆油，芝麻油，玉米胚芽油，油菜籽油，棉子油中的一种或一种以上。
所述糖类为麦芽糖，蔗糖，果糖，葡萄糖，甘露糖，饴糖，红糖中的一种或一种以上。
所述维生素为维生素A，维生素B1，维生素B2，维生素B6，维生素C，维生素D，维生素E，维生素K，维生素PP中的一种或一种以上。
所述矿物质为麦饭石粉，碳酸钙，碳酸钠，硫酸镁，硫酸锌，碳酸铁中的一种或一种以上。
所述天然植物干粉末为树灰藓干粉末，肿足蕨干粉末，泽泻蕨干粉末中的一种或一种以上。
所述增稠剂为卡拉胶，瓜尔胶，黄原胶，阿拉伯胶，明胶，桃胶中的一种或一种以上。
所述抗氧化剂为胡萝卜素，谷胱甘肽，硫代巴比士酸，虾青素，角黄素，叶黄素中的一种或一种以上。
本发明的有益效果：本发明制备的肝病临床营养食品，具有护肝养肝的功效，选取天然植物干粉末作为护肝养肝的活性组分，配合蛋白质，脂肪，糖类，淀粉等营养物质，以及维生素，矿物质，抗氧化剂等有益因子，最大化恢复肝病病人的肝脏功能。
具体实施方式
下面结合具体实施例对本发明做进一步说明。
实施例1
一种肝病临床营养配方，由如下重量份数的组分组成：鱼粉400份，猪油150份，麦芽糖160份，淀粉450份，维生素A 0.02份，维生素C 0.02份，维生素D 0.02份，维生素E 0.02份，维生素B6 0.02份，麦饭石粉5份，树灰藓干粉末20份，黄原胶60份，胡萝卜素0.5份。
实施例2
一种肝病临床营养配方，由如下重量份数的组分组成：肉粉300份，花生油100份，蔗糖120份，淀粉300份，维生素A 0.01份，维生素B1 0.01份，维生素B2 0.01份，维生素B6 0.01份，维生素C 0.01份，碳酸钙1份，硫酸镁1份，硫酸锌1份，肿足蕨干粉末10份，瓜尔胶15份，谷胱甘肽0.1份。
实施例3
一种肝病临床营养配方，由如下重量份数的组分组成：蛋白胨500份，大豆油200份，果糖230份，淀粉600份，维生素C 0.2份，维生素D 0.2份，维生素E 0.2份，维生素K 0.2份，维生素PP 0.2份，碳酸钙2份，碳酸钠2份，硫酸镁2份，硫酸锌2份，泽泻蕨干粉末30份，明胶80份，虾青素2份。
实施例4
一种肝病临床营养配方，由如下重量份数的组分组成：三虫粉400份，猪油150份，麦芽糖160份，淀粉450份，维生素A 0.02份，维生素C 0.02份，维生素D 0.02份，维生素E 0.02份，维生素B6 0.02份，麦饭石粉5份，树灰藓干粉末20份，黄原胶60份，胡萝卜素0.5份。
实施例5
一种肝病临床营养配方，由如下重量份数的组分组成：鱼粉400份，猪油150份，麦芽糖160份，淀粉450份，维生素A 0.02份，维生素C 0.02份，维生素D 0.02份，维生素E 0.02份，维生素B6 0.02份，麦饭石粉5份，树灰藓干粉末20份，二药藻5份，黄原胶60份，胡萝卜素0.5份。
实施例6
一种肝病临床营养配方，由如下重量份数的组分组成：鱼粉400份，猪油150份，麦芽糖160份，淀粉450份，维生素A 0.02份，维生素C 0.02份，维生素D 0.02份，维生素E 0.02份，维生素B6 0.02份，麦饭石粉5份，树灰藓干粉末20份，黄原胶60份，胡萝卜素0.5份，1-癸烯-3-醇0.1份。
对比例1
一种肝病临床营养配方，由如下重量份数的组分组成：鱼粉400份，猪油150份，麦芽糖160份，淀粉450份，维生素A 0.02份，维生素C 0.02份，维生素D 0.02份，维生素E 0.02份，维生素B6 0.02份，麦饭石粉5份，黄原胶60份，胡萝卜素0.5份。
实验例：
取清洁级雄性 NIH 小鼠900 只，体重 18 ～ 22g，分为7组；喂养 1 周适应环境后，自由摄食饮水、基础饲料正常供给 ； 每组每天分别给予营养配方 80g/kg bw，进食营养配方结束后给予基础饲料，连续 7 周，自由摄食饮水。
亚急性肝损伤模型的诱导 ：小鼠从实验第 1 天起腹腔注射0.3％的 CCl4 玉米油溶液，剂量为 10ml/kg bw，每周注射 2 次，共注射 3 周，以诱导化学性亚急性肝损伤动物模型。末次注射 CCl4 后禁食 8 小时，眼眶后静脉丛采血测定血清谷 丙转氨酶 (ALT)和谷草转氨酶 (AST) 水平，评价肝损伤模型是否诱导成功。肝损伤模型诱导成功后继续按原方案予以喂食。7 周后，各组小鼠禁食 12 小时，摘除眼球采血制备血清， 测定 ALT 和AST。营养配方对 CCl4 亚急性肝损伤小鼠血清肝酶活性的影响如表1所示：
表1营养膳对 CCl4 亚急性肝损伤小鼠 3w、 7w 时血清肝酶活性的影响
表中同列不同字母表示有显著差异 (p<0.05)。
由表1可以看出，小鼠造模 3 周后，与正常对照组比，肝损伤模型组血清 ALT、AST 活性显著升高 (P<0.05)，实施例1-6与模型组相比，血清中的肝酶活有降低趋势，继续给小鼠喂食至7周末，模型组血清ALT、 AST活性仍显著高于正常对照组(P<0.05) ； 与模型组相比，实施例1-6可显著地抑制CCl4 引起的血清ALT和AST的升高， 表明本发明营养膳对CCl4 亚急性肝损伤小鼠具有肝损伤保护作用。小鼠造模 3 周和7周，对比例1的ALT、 AST活性与模型组相当，显著高于实施例1，与实施例1相比，其他实验条件完全相同，仅仅是对比例1少加入了树灰藓干粉末，可见树灰藓干粉末具有肝损伤保护作用；实施例4-6的血清ALT、 AST活性降低效果优于实施例1，与实施例1相比，其他实验条件完全相同，仅仅是实施例4将三虫粉替代为实施例1鱼粉，实施例5和6中分别多加入了二药藻和1-癸烯-3-醇；可见二药藻和1-癸烯-3-醇具有肝损伤保护作用。
Claims (10)
1.一种肝病临床营养配方，其特征在于，由如下重量份数的组分组成：蛋白质300-500份，脂肪100-200份，糖类120-230份，淀粉300-600份，维生素0.05-1份，矿物质3-8份，天然植物干粉末10-30份，增稠剂15-80份，抗氧化剂0.1-2份。
2.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述蛋白质为鱼粉，肉粉，蛋白胨，酵母提取物中的一种或一种以上。
3.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述蛋白质为三虫粉。
4.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述脂肪为猪油，花生油，大豆油，芝麻油，玉米胚芽油，油菜籽油，棉子油中的一种或一种以上。
5.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述糖类为麦芽糖，蔗糖，果糖，葡萄糖，甘露糖，饴糖，红糖中的一种或一种以上。
6.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述维生素为维生素A，维生素B1，维生素B2，维生素B6，维生素C，维生素D，维生素E，维生素K，维生素PP中的一种或一种以上。
7.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述矿物质为麦饭石粉，碳酸钙，碳酸钠，硫酸镁，硫酸锌，碳酸铁中的一种或一种以上。
8.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述天然植物干粉末为树灰藓干粉末，肿足蕨干粉末，泽泻蕨干粉末中的一种或一种以上。
9.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述增稠剂为卡拉胶，瓜尔胶，黄原胶，阿拉伯胶，明胶，桃胶中的一种或一种以上。
10.根据权利要求1所述一种肝病临床营养配方，其特征在于，所述抗氧化剂为胡萝卜素，谷胱甘肽，硫代巴比士酸，虾青素，角黄素，叶黄素中的一种或一种以上。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710808664.4A CN107510044B (zh) | 2017-09-09 | 2017-09-09 | 一种肝病临床营养配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710808664.4A CN107510044B (zh) | 2017-09-09 | 2017-09-09 | 一种肝病临床营养配方及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107510044A true CN107510044A (zh) | 2017-12-26 |
| CN107510044B CN107510044B (zh) | 2020-07-24 |
Family
ID=60725401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710808664.4A Active CN107510044B (zh) | 2017-09-09 | 2017-09-09 | 一种肝病临床营养配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107510044B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108618007A (zh) * | 2018-05-06 | 2018-10-09 | 范玉武 | 一种鲤鱼鱼糜的制备方法 |
| CN108813436A (zh) * | 2018-07-10 | 2018-11-16 | 曾杨列 | 具有增强免疫力的营养强化剂及在保健休闲食品中的应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1406589A (zh) * | 2001-09-11 | 2003-04-02 | 北京中科天鹤生物技术有限公司 | 一种具有护肝养胃功能的昆虫保健品及其制备方法 |
| CN105558046A (zh) * | 2016-01-12 | 2016-05-11 | 刘保惠 | 一种用于肝病患者的特殊医学用途配方食品及其制备方法 |
| CN106605908A (zh) * | 2016-05-27 | 2017-05-03 | 韶关邦世迪健康实业有限公司 | 一种肝病用特殊需医学用途全营养配方产品 |
| CN106962912A (zh) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | 一种肝病专用型临床营养配方及其制备方法 |
-
2017
- 2017-09-09 CN CN201710808664.4A patent/CN107510044B/zh active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1406589A (zh) * | 2001-09-11 | 2003-04-02 | 北京中科天鹤生物技术有限公司 | 一种具有护肝养胃功能的昆虫保健品及其制备方法 |
| CN105558046A (zh) * | 2016-01-12 | 2016-05-11 | 刘保惠 | 一种用于肝病患者的特殊医学用途配方食品及其制备方法 |
| CN106605908A (zh) * | 2016-05-27 | 2017-05-03 | 韶关邦世迪健康实业有限公司 | 一种肝病用特殊需医学用途全营养配方产品 |
| CN106962912A (zh) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | 一种肝病专用型临床营养配方及其制备方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108618007A (zh) * | 2018-05-06 | 2018-10-09 | 范玉武 | 一种鲤鱼鱼糜的制备方法 |
| CN108618007B (zh) * | 2018-05-06 | 2021-12-10 | 上海高更食品科技股份有限公司 | 一种鲤鱼鱼糜的制备方法 |
| CN108813436A (zh) * | 2018-07-10 | 2018-11-16 | 曾杨列 | 具有增强免疫力的营养强化剂及在保健休闲食品中的应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107510044B (zh) | 2020-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liang et al. | Current microalgal health food R & D activities in China | |
| CN104855845A (zh) | 一种纳豆营养健康食品 | |
| CN103054007A (zh) | 一种提高人体免疫力的野生菌组合物 | |
| CN104432035B (zh) | 增强免疫力的保健营养组合物及其制备方法与应用 | |
| CN106360739A (zh) | 一种调节血压、降低血糖、补充营养的组合物 | |
| CN104336144A (zh) | 一种同步调节高血糖高血压高血脂及免疫功能的食用饼干 | |
| CN104855997A (zh) | 骨质疏松非全营养配方食品 | |
| CN101664180B (zh) | 一种具有保健功效的营养复合剂及其制备方法 | |
| CN105533446A (zh) | 一种具有保健作用的营养麦片及其制备方法 | |
| CN107510044A (zh) | 一种肝病临床营养配方及其制备方法 | |
| CN104839695A (zh) | 炎性肠病非全营养配方食品 | |
| CN104839698A (zh) | 心血管疾病非全营养配方食品 | |
| CN105494843A (zh) | 一种蓝莓压片糖果制备方法 | |
| CN109043553A (zh) | 一种妊娠糖尿病患者食用的特殊食品及其制备方法 | |
| CN102813199A (zh) | 一种预防及辅助治疗癌症、三高症及增强免疫力的保健食品 | |
| CN104872646A (zh) | 大肠癌非全营养配方食品 | |
| CN104256193A (zh) | 一种抗病均衡营养幼年甲鱼料配方 | |
| CN104855992A (zh) | 前列腺癌全营养配方食品 | |
| CN104855969A (zh) | 肝病非全营养配方食品 | |
| CN104839699A (zh) | 心脏病非全营养配方食品 | |
| CN107549692A (zh) | 一种用于化疗患者术后恢复的海洋多肽特膳食品 | |
| CN107136490A (zh) | 一种肽虫草保健品 | |
| WO2009116507A1 (ja) | 経腸栄養剤 | |
| CN101766306A (zh) | 美体金针菇多糖保健胶囊 | |
| CN1298229C (zh) | 一种微米糖参银耳养颜润肺降糖奶片制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210608 Address after: 272000 Jining public health medical center, jiumigudui, Rencheng District, Jining City, Shandong Province Patentee after: Jining public health medical center Address before: 272031 Jiudui Infectious Diseases Hospital, Rencheng District, Jining City, Shandong Province Patentee before: Li Shaobo |